Milestone Scientific Inc. (MLSS)

Milestone Scientific Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	9.48	9.83	8.81	10.3	5.44	8.37
Revenue Growth (YoY)	8.92%	11.60%	-14.54%	89.52%	-35.07%	-12.97%
Cost of Revenue	2.9	3.03	3.91	3.99	1.82	2.66
Gross Profit	6.58	6.79	4.9	6.31	3.62	5.72
Selling, General & Admin	13.1	13.14	12.51	12.74	10.67	9.53
Research & Development	0.66	0.7	1.15	0.88	0.31	0.19
Other Operating Expenses	0.06	0.06	0.06	0.07	0.1	0
Operating Expenses	13.81	13.9	13.73	13.69	11.07	9.72
Operating Income	-7.23	-7.11	-8.83	-7.38	-7.45	-4
Interest Expense / Income	-0.17	-0.13	-0.05	0.02	0.02	0
Other Expense / Income	0	-0.05	-0.07	-0.58	-0.15	3.51
Pretax Income	-7.06	-6.93	-8.71	-6.82	-7.32	-7.51
Income Tax	0	0	0	0	0.02	0.02
Net Income	-7.06	-6.93	-8.71	-6.82	-7.34	-7.52
Shares Outstanding (Basic)	80	73	71	69	63	46
Shares Outstanding (Diluted)	80	73	71	69	63	46
Shares Change	10.59%	3.07%	2.58%	9.15%	37.87%	29.58%
EPS (Basic)	-0.10	-0.10	-0.12	-0.10	-0.12	-0.16
EPS (Diluted)	-0.10	-0.10	-0.12	-0.10	-0.12	-0.16
Free Cash Flow	-4.54	-5.33	-6.04	-4.05	-7.01	-1.79
Free Cash Flow Per Share	-0.06	-0.07	-0.09	-0.06	-0.11	-0.04
Gross Margin	69.42%	69.12%	55.65%	61.25%	66.60%	68.28%
Operating Margin	-76.26%	-72.31%	-100.24%	-71.60%	-137.08%	-47.75%
Profit Margin	-74.50%	-70.51%	-98.87%	-66.17%	-134.94%	-89.85%
Free Cash Flow Margin	-47.94%	-54.25%	-68.60%	-39.29%	-128.86%	-21.36%
EBITDA	-7.09	-6.9	-8.62	-6.65	-7.17	-7.41
EBITDA Margin	-74.75%	-70.25%	-97.85%	-64.57%	-131.93%	-88.43%
Depreciation & Amortization	0.15	0.15	0.14	0.15	0.13	0.1
EBIT	-7.23	-7.05	-8.76	-6.8	-7.3	-7.51
EBIT Margin	-76.31%	-71.79%	-99.49%	-66.00%	-134.33%	-89.63%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).